Clinical Experience with Cerebrospinal Fluid A42, Total and Phosphorylated Tau in the Evaluation of 1,016 Individuals for Suspected Dementia

Nav

General Info

Geography

United States of America (USA)

New York

Time period covered

01/2005 - 12/2017

Data type

Scientific literature

Keywords

Alzheimer's disease and other dementias

Citation

Authors

Tariciotti L, Casadei M, Honig LS, Teich AF, McKhann Ii GM, Tosto G, Mayeux R

Journal

J Alzheimers Dis

Volume

Issue

Pages

1417-1425

Publication year

2018

Suggested citation

Tariciotti L, Casadei M, Honig LS, Teich AF, McKhann Ii GM, Tosto G, Mayeux R. Clinical Experience with Cerebrospinal Fluid A42, Total and Phosphorylated Tau in the Evaluation of 1,016 Individuals for Suspected Dementia. J Alzheimers Dis. 2018; 65(4): 1417-1425.

DOI

10.3233/JAD-180548

PMID

30149454

GHDx Entry last modified on: Jan 31, 2024

Header sites

Search form

Main menu

Clinical Experience with Cerebrospinal Fluid A42, Total and Phosphorylated Tau in the Evaluation of 1,016 Individuals for Suspected Dementia

Nav